Shandong Ruiying Pharmaceutical Group Co., Ltd.

Founded in 1990, Shandong Ruiying Pioneer Pharmaceutical Co.,Ltd. is a large pharmaceutical manufacturing company which integrates R&D, pilot production, production and sales, and affiliated to Shandong Ruiying•Runze Pharmaceutical Group. The company is mainly engaged in developing, producing and selling the preparations, APIs and intermediates of cephalosporins, penicillins antibiotics and antineoplastic drugs. The company focuses on product development and technical innovation, and successively developed more than 100 products, over 40 of which obtained provincial certificates for scientific and technological achievement, and 70 patents were applied. With GCLE and latamoxef coming to the market, they filled in the blanks of China. The company was inspected and awarded various official certificates, such as the new version of China GMP certificate, Korea KFDA certificate, US FDA certificate, EDQM certificate, Brazil ANVISA certificate, China EHS certificate, etc. And the group ranked top 100 pharmaceutical industry enterprises for several successive years. With our own advantages of the group, we strengthen innovations and continuously expand the market. Our products are not only sold domestically, but also are exported to Europe, the United States and over a dozen countries. The production technology and the quality of leading products have been highly praised by domestic and overseas clients.